Prescription drug · ANDA
cisatracurium besylate NDC 72785-0008
Cisatracurium besylate 2 mg/mL · Injection · Intravenous · Zydus Lifesciences Limited
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 72785-0008-6 | 7278500080672785000806 | 10 VIAL in 1 CARTON (72785-0008-6) / 5 mL in 1 VIAL (72785-0008-1)Marketed from Feb 12, 2020 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- cisatracurium besylate
- Generic name (nonproprietary)
- cisatracurium besylate
- Active ingredients
- Cisatracurium besylate — 2 mg/mL
- Dosage form
- Injection
- Route
- Intravenous
- Labeler
- Zydus Lifesciences LimitedNDC labeler code 72785
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 212171
- Marketing start
- Listing expires
- Other FDA classes
- Neuromuscular Nondepolarizing Blockade (Physiologic effect)
- Identifiers
- Product ID 72785-0008_1b257332-a1a5-406e-86e4-283580657dc6SPL ID 1b257332-a1a5-406e-86e4-283580657dc6SPL set ID e145a40e-b046-4064-b35e-0da40ff3703eRxCUI 199212, 1730194UNII 80YS8O1MBS
- Pharmacologic class
- Nondepolarizing Neuromuscular Blocker
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N472785000806followed by a unit qualifier and the quantityPackage 72785-0008-06. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
About NDC 72785-0008
- What is NDC 72785-0008?
- 72785-0008 is the product NDC for cisatracurium besylate, Cisatracurium besylate 2 mg/mL injection, listed with the FDA by Zydus Lifesciences Limited. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- cisatracurium besylate.
- What is the active ingredient?
- Cisatracurium besylate.
- Who is the labeler?
- Zydus Lifesciences Limited, NDC labeler code 72785. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for cisatracurium besylate?
- 34 other product NDCs are listed under this name. See all cisatracurium besylate NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other cisatracurium besylate products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Cisatracurium Besylate | Cisatracurium besylate 10 mg/mL | Injection, SolutionIntravenous | Avenacy, LLC | 83634-655 | 83634-0655-20 |
| Cisatracurium Besylate | Cisatracurium besylate 10 mg/mL | InjectionIntravenous | Camber Pharmaceuticals Inc. | 31722-312 | 31722-0312-10 |
| Cisatracurium Besylate | Cisatracurium besylate 2 mg/mL | InjectionIntravenous | Camber Pharmaceuticals Inc. | 31722-313 | 31722-0313-10 |
| Cisatracurium Besylate | Cisatracurium besylate 2 mg/mL | InjectionIntravenous | Camber Pharmaceuticals Inc. | 31722-314 | 31722-0314-10 |
| Cisatracurium besylate | Cisatracurium besylate 2 mg/mL | InjectionIntravenous | Gland Pharma Limited | 68083-486 | 68083-0486-01 |
| Cisatracurium besylate | Cisatracurium besylate 10 mg/mL | InjectionIntravenous | Gland Pharma Limited | 68083-487 | 68083-0487-01 |
| Cisatracurium besylate | Cisatracurium besylate 2 mg/mL | InjectionIntravenous | Gland Pharma Limited | 68083-488 | 68083-0488-01 |
| Cisatracurium Besylate | Cisatracurium besylate 10 mg/mL | InjectionIntravenous | Hikma Pharmaceuticals USA Inc. | 0143-9160 | 00143-9160-10 |
| Cisatracurium Besylate | Cisatracurium besylate 2 mg/mL | InjectionIntravenous | Hikma Pharmaceuticals USA Inc. | 0143-9397 | 00143-9397-10 |
| Cisatracurium besylate | Cisatracurium besylate 2 mg/mL | InjectionIntravenous | Caplin Steriles Limited | 65145-135 | 65145-0135-0165145-0135-10 |
Other NDCs under ANDA 212171
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| cisatracurium besylate | Cisatracurium besylate 2 mg/mL | InjectionIntravenous | Zydus Pharmaceuticals USA Inc. | 70710-1532 |
| cisatracurium besylate | Cisatracurium besylate 10 mg/mL | InjectionIntravenous | Zydus Pharmaceuticals USA Inc. | 70710-1534 |
| cisatracurium besylate | Cisatracurium besylate 10 mg/mL | InjectionIntravenous | Zydus Lifesciences Limited | 72785-0009 |